External resources
Current NHS consultant posts held
Consultant specialising in Retina at St Thomas' Hospital and is also the Clinical Lead for the Lambeth, Lewisham and Southwark Diabetic Eye Screening Programme.
Research interests
Samantha Mann (nee Dandekar) completed an MD in age-related macular degeneration at Moorfield's Eye Hospital from 2001-2003 resulting in a number of publications including papers about autofluorescence imaging of the retina. Since then her main interest has been in diabetes and diabetic retinopathy and treatments including intravitreal anti-VEGF injections and laser treatments.
Personal interests
Skiing, Travelling, Food & Wine
Awards received
Harcourt Medal (June 2001)
Publications
1)Dandekar SS, Jenkins S, Peto T, Bird A, Webster AR. Does smoking influence the type of AMD causing visual impairment. BJO 2006
2)Mann SS, Rutishauser-Arnold Y, Peto T, Jenkins SA, Leung I, Xing W, Bird AC, Bunce C, Webster AR. The symmetry of phenotype between eyes. (AMD). Graefes Arch Clin Exp Ophthalmol. 2010 Aug
3) Sivaprasad S, Gupta B, Gulliford MC, Dodhia H, Mann S, Nagi D, Evans J. (DRIVE UK Study). PLoS One. 2012;7(6)
4) Non-attendance at diabetic eye screening and risk of sight-threatening diabetic retinopathy : a population-based cohort study. / Forster, Alice; Forbes, Angus; Dodhia, H.; Connor, Clare; Du Chemin, Alain; Sivaprasad, Sobha; Mann, Samantha; Gulliford, Martin.
In: Diabetologia, 2013.
5) Changes in Detection of Retinopathy in Type 2 Diabetes in the First 4 Years of a Population-Based Diabetes Eye Screening Program : Retrospective cohort study. Forster, A., Forbes, A., Dodhia, H., Connor, C., Du Chemin, A., Sivaprasad, S., Mann, S. & Gulliford, M. 2013 In : Diabetes Care.
6) R. Welikala, Dehmeshki, A. Hoppe, V. Tah, S Mann, T Williamson. Automated detection of proliferative diabetic retinopathy using a modified line operator and dual classification. Computer Methods and Programs in Biomedicine. 114 (3). May 2014.
7) S.Mann- Addressing Medical Retinal Risk Factors in Diabetes and Understanding newer systemic treatments in Diabetes. Eye News April/May 2014.
8) S.Mann- Treatment of Diabetic Macular Oedema. Eye News. July/Aug 2014
9) Mahroo et al. Cilioretinal Artery Territory Infarction Associated With Papilledema in a Patient With Neurofibromatosis Type 2.
Journal of Neuro-Ophthalmol. 2015.
10) Cilioretinal Artery Territory Infarction Associated With Papilledema in a Patient With Neurofibromatosis Type 2.
Mahroo OA, Mohamed MD, Graham EM, Mann SS, Plant GT, Afridi SK, Hammond CJ.
J Neuroophthalmol. 2015 Aug 20.
11) Prevalence of vitreomacular interface abnormalities on spectral domain optical coherence tomography of patients undergoing macular photocoagulation for centre involving diabetic macular oedema.
Akbar Khan I, Mohamed MD, Mann SS, Hysi PG, Laidlaw DA.
Br J Ophthalmol. 2015 Aug;99(8):1078-81. doi: 10.1136/bjophthalmol-2014-305966.
12) Genetic Algorithm Based Feature Selection Combined with Dual classification for the automated Detection of Proliferative Diabetic Retinopathy. Roshan Welikala.M Fraz,J Dehmeshki, A Hope, V Tah, S S Mann,T williamson, S A Barman. March 2015.Computerised medical imaging and Graphics.
Courses offered to GPs
Intermittant seminars at the London Medical and at St Thomas' Hospital on Diabetes and the Eye.